MA TRAD Other TRAD Italy MA TRAD / MA TRAD Other TRAD Sweden MA TRAD / Member State Regulatory Status Austria MA TRAD / MA TRAD Other TRAD Czech Republic MA TRAD / MA TRAD Other TRAD Romania MA TRAD / MA TRAD Other TRAD / MA TRAD Other TRAD Greece MA TRAD / MA TRAD Other TRAD Portugal MA TRAD / MA TRAD Other TRAD Luxemburg MA TRAD / MA TRAD Other TRAD Poland MA TRAD / MA TRAD Other TRAD Lithuania MA TRAD / MA TRAD Other TRAD Latvia MA TRAD / MA TRAD Other TRAD Slovenia MA TRAD / MA TRAD Other TRAD Ireland MA TRAD / MA TRAD Other TRAD United Kingdom MA TRAD / MA TRAD Other TRAD Liechtenstein MA TRAD / MA TRAD Other TRAD Cyprus MA TRAD / MA TRAD Other TRAD Iceland MA TRAD / MA TRAD Other TRAD Malta MA TRAD / MA TRAD Other TRAD Finland MA TRAD / MA TRAD Other TRAD Germany MA TRAD / Norway MA TRAD / MA TRAD Other TRAD Estonia MA TRAD / MA TRAD Other TRAD Slovak Republic MA TRAD / MA TRAD Other TRAD France MA TRAD / TRAD Other TRAD Bulgaria MA TRAD Other TRAD / The Netherlands MA TRAD / MA TRAD Other TRAD Spain MA TRAD / MA TRAD Other TRAD Hungary MA TRAD / MA TRAD Other TRAD Denmark MA TRAD / /
Country
Germany / Romania / Belgium / France / United States / Iran / /
Currency
pence / / /
Event
FDA Phase / /
Facility
University of Ghent / Canary Wharf / / /
IndustryTerm
volatile oil / treatment of such disorders / natural products / important breakdown products / important transformation site / prenyl / treatment of sleep disturbances / degradation product / oxidation products / minor degradation products / treatment of a variety of gynaecological disorders / oil / combination products / chemical structure / liquid pharmaceutical forms / medicinal products / herbal medicinal products / /
Organization
COMMITTEE ON HERBAL MEDICINAL PRODUCTS / University of Ghent / European Medicines Agency / /
Person
A. J. Vlietinck / Talahay / A. Gray (Annonaceae) / Flores Humuli / / /
European Medicines Agency Evaluation of Medicines for Human Use